ArticlePharmaceutical research2018
Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration.
Alex Karlsson-Parra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it